448477122
02 Nov 2019
Toward The Commercialization Of A Proteolytically Resistant Appi Variant For Inhibiting Metastasis In Prostate And Pancreatic Cancer, Israel
30 Apr 2021
N/A
Healthcare and Medical Tenders , Consultancy Tenders , Services Tenders
Project Information
Click for more details
If you have forgotten your User ID or Password, then please contact the TendersInfo Customercare by Email on customercare@tendersinfo.com.